Multiple sclerosis: interferon-beta induces CD123(+)BDCA2- dendritic cells that produce IL-6 and IL-10 and have no enhanced type I interferon production. [electronic resource]
Producer: 20050307Description: 204-12 p. digitalISSN:- 0165-5728
- Adult
- Cell Count -- methods
- Cells, Cultured
- Dendritic Cells -- drug effects
- Disability Evaluation
- Enzyme-Linked Immunosorbent Assay -- methods
- Female
- Flow Cytometry -- methods
- Humans
- Interferon-beta -- pharmacology
- Interleukin-10 -- metabolism
- Interleukin-3 Receptor alpha Subunit
- Interleukin-6 -- metabolism
- Male
- Middle Aged
- Multiple Sclerosis -- drug therapy
- Receptors, Interleukin-3 -- metabolism
- Sendai virus -- pathogenicity
- Simplexvirus -- pathogenicity
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.